242 related articles for article (PubMed ID: 25263130)
1. System a amino acid transport-targeted brain and systemic tumor PET imaging agents 2-amino-3-[(18)F]fluoro-2-methylpropanoic acid and 3-[(18)F]fluoro-2-methyl-2-(methylamino)propanoic acid.
Yu W; McConathy J; Olson JJ; Goodman MM
Nucl Med Biol; 2015 Jan; 42(1):8-18. PubMed ID: 25263130
[TBL] [Abstract][Full Text] [Related]
2. Radiolabeled amino acids for tumor imaging with PET: radiosynthesis and biological evaluation of 2-amino-3-[18F]fluoro-2-methylpropanoic acid and 3-[18F]fluoro-2-methyl-2-(methylamino)propanoic acid.
McConathy J; Martarello L; Malveaux EJ; Camp VM; Simpson NE; Simpson CP; Bowers GD; Olson JJ; Goodman MM
J Med Chem; 2002 May; 45(11):2240-9. PubMed ID: 12014962
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, radiolabeling, and biological evaluation of (R)- and (S)-2-amino-3-[(18)F]fluoro-2-methylpropanoic acid (FAMP) and (R)- and (S)-3-[(18)F]fluoro-2-methyl-2-N-(methylamino)propanoic acid (NMeFAMP) as potential PET radioligands for imaging brain tumors.
Yu W; McConathy J; Williams L; Camp VM; Malveaux EJ; Zhang Z; Olson JJ; Goodman MM
J Med Chem; 2010 Jan; 53(2):876-86. PubMed ID: 20028004
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, Radiolabeling, and Biological Evaluation of (R)- and (S)-2-Amino-5-[(18)F]fluoro-2-methylpentanoic Acid ((R)-, (S)-[(18)F]FAMPe) as Potential Positron Emission Tomography Tracers for Brain Tumors.
Bouhlel A; Zhou D; Li A; Yuan L; Rich KM; McConathy J
J Med Chem; 2015 May; 58(9):3817-29. PubMed ID: 25843369
[TBL] [Abstract][Full Text] [Related]
5.
Nodwell MB; Yang H; Merkens H; Malik N; Čolović M; Björn Wagner ; Martin RE; Bénard F; Schaffer P; Britton R
J Nucl Med; 2019 Jul; 60(7):1003-1009. PubMed ID: 30683769
[TBL] [Abstract][Full Text] [Related]
6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
7. Comparative Evaluation of [
Colovic M; Yang H; Southcott L; Merkens H; Colpo N; Bénard F; Schaffer P
J Nucl Med; 2023 Aug; 64(8):1314-1321. PubMed ID: 37116917
[TBL] [Abstract][Full Text] [Related]
8. Transport of 3-fluoro-L-α-methyl-tyrosine by tumor-upregulated L-type amino acid transporter 1: a cause of the tumor uptake in PET.
Wiriyasermkul P; Nagamori S; Tominaga H; Oriuchi N; Kaira K; Nakao H; Kitashoji T; Ohgaki R; Tanaka H; Endou H; Endo K; Sakurai H; Kanai Y
J Nucl Med; 2012 Aug; 53(8):1253-61. PubMed ID: 22743251
[TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of transport mechanisms of trans-1-amino-3-[¹⁸F]fluorocyclobutanecarboxylic acid and L-[methyl-¹¹C]methionine in human glioma cell lines.
Ono M; Oka S; Okudaira H; Schuster DM; Goodman MM; Kawai K; Shirakami Y
Brain Res; 2013 Oct; 1535():24-37. PubMed ID: 23994214
[TBL] [Abstract][Full Text] [Related]
10. Fluorine-18-Labeled PET Radiotracers for Imaging Tryptophan Uptake and Metabolism: a Systematic Review.
John F; Muzik O; Mittal S; Juhász C
Mol Imaging Biol; 2020 Aug; 22(4):805-819. PubMed ID: 31512038
[TBL] [Abstract][Full Text] [Related]
11. Novel
Hanaoka H; Ohshima Y; Yamaguchi A; Suzuki H; Ishioka NS; Higuchi T; Arano Y; Tsushima Y
Mol Pharm; 2019 Aug; 16(8):3609-3616. PubMed ID: 31242385
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of bladder cancer using
Mahendra I; Hanaoka H; Yamaguchi A; Amartuvshin T; Tsushima Y
Ann Nucl Med; 2020 May; 34(5):329-336. PubMed ID: 32144655
[TBL] [Abstract][Full Text] [Related]
13. Radiopharmacological evaluation of 6-deoxy-6-[18F]fluoro-D-fructose as a radiotracer for PET imaging of GLUT5 in breast cancer.
Wuest M; Trayner BJ; Grant TN; Jans HS; Mercer JR; Murray D; West FG; McEwan AJ; Wuest F; Cheeseman CI
Nucl Med Biol; 2011 May; 38(4):461-75. PubMed ID: 21531283
[TBL] [Abstract][Full Text] [Related]
14. Exploration of the impact of stereochemistry on the identification of the novel translocator protein PET imaging agent [(18)F]GE-180.
Chau WF; Black AM; Clarke A; Durrant C; Gausemel I; Khan I; Mantzilas D; Oulie I; Rogstad A; Trigg W; Jones PA
Nucl Med Biol; 2015 Sep; 42(9):711-9. PubMed ID: 26072270
[TBL] [Abstract][Full Text] [Related]
15. Direct comparison of 2‑amino[3‑11C]isobutyric acid and 2‑amino[11C]methyl‑isobutyric acid uptake in eight lung cancer xenograft models.
Sudo H; Tsuji AB; Sugyo A; Okada M; Kato K; Zhang MR; Saga T; Higashi T
Int J Oncol; 2018 Dec; 53(6):2737-2744. PubMed ID: 30334568
[TBL] [Abstract][Full Text] [Related]
16. Functional imaging of oxidative stress with a novel PET imaging agent, 18F-5-fluoro-L-aminosuberic acid.
Webster JM; Morton CA; Johnson BF; Yang H; Rishel MJ; Lee BD; Miao Q; Pabba C; Yapp DT; Schaffer P
J Nucl Med; 2014 Apr; 55(4):657-64. PubMed ID: 24578242
[TBL] [Abstract][Full Text] [Related]
17. Biological evaluation of 3-[(18)F]fluoro-α-methyl-D-tyrosine (D-[(18)F]FAMT) as a novel amino acid tracer for positron emission tomography.
Ohshima Y; Hanaoka H; Tominaga H; Kanai Y; Kaira K; Yamaguchi A; Nagamori S; Oriuchi N; Tsushima Y; Endo K; Ishioka NS
Ann Nucl Med; 2013 May; 27(4):314-24. PubMed ID: 23337966
[TBL] [Abstract][Full Text] [Related]
18. Impact of structural alterations on the radiopharmacological profile of
Tietz O; Marshall A; Bergman C; Wuest M; Wuest F
Nucl Med Biol; 2018; 62-63():9-17. PubMed ID: 29800798
[TBL] [Abstract][Full Text] [Related]
19. Effect of α-Methyl versus α-Hydrogen Substitution on Brain Availability and Tumor Imaging Properties of Heptanoic [F-18]Fluoroalkyl Amino Acids for Positron Emission Tomography (PET).
Bouhlel A; Alyami W; Li A; Yuan L; Rich K; McConathy J
J Med Chem; 2016 Apr; 59(7):3515-31. PubMed ID: 26967318
[TBL] [Abstract][Full Text] [Related]
20. Biological evaluation of new [(18) F]F-labeled synthetic amino acid derivatives as oncologic radiotracers.
Kim Y; Lee SJ; Yook CM; Oh SJ; Ryu JS; Lee JJ
J Labelled Comp Radiopharm; 2016 Aug; 59(10):404-10. PubMed ID: 27397697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
